The presence of lipopolysaccharide (LPS) in the middle ear may have a modulatory effect on the establishment of the allergic conditions that facilitate recurrent otitis media with effusion and Eustachian tube (ET) dysfunction. Our objectives were to: 1) Establish allergic ET dysfunction in rats via transtympanic (TT) exposure to ovalbumin (OVA). 2) Modulate the nature of the immune response to OVA by varying the concentration of LPS. 3) Understand the role of LPS exposure in the middle ear on the development of allergy. METHOD: Brown-Norway rats were randomized to four groups: I) non-allergic control; II) OVA only; III) OVA and low-dose LPS; and IV) OVA and high-dose LPS. Group I received TT phosphate-buffered saline, while group II received TT OVA. Groups III and IV received TT OVA and simultaneously received either low-dose TT LPS or high-dose TT LPS. All groups were transtympanically challenged with OVA two weeks after initial exposure. Immediately after OVA challenge, the dynamic function of the ET was assessed by the following measures: passive opening pressure, passive closing pressure, and mucociliary transit time. These measures were analyzed across groups by ANOVA. Statistical significance was determined prior to the experiment for p values of Ͻ0.05 and a power of 0.80. RESULTS: The low-dose LPS group was found to have significantly increased passive opening pressures, passive closing pressures, and mucociliary clearance times (p0.05). CONCLUSION: Results indicate that the presence of LPS in the middle ear during antigen presentation has an effect on the immune response to that antigen, and that the nature of the effect varies with LPS concentration. Specifically, low doses of LPS appear to augment the development of allergy when presented simultaneously with OVA, while high doses of LPS appear to inhibit the development of allergy.
The Effect of Macrolides in Nasal Polyp-Derived Fibroblasts
You-Mi Lee (presenter); Jung-Sun Cho; Il-Ho Park, MD; Yong-Dae Kim, MD, PhD; Heung-Man Lee, MD, PhD OBJECTIVE: Determine the effect of macrolides (erythromycin, EM; roxithromycin, RXM) on the differentiation of fibroblasts into myofibroblasts and extracellular matrix accumulation in transforming growth factor (TGF) ␤1-induced nasal polyp-derived fibroblasts (NPDFs), and to determine if Nox4 and reactive oxygen species (ROS) are involved in the above processes. METHOD: Nasal polyps of six patients (three females and three males; 32.35.2 years of age) were acquired during surgery and NPDFs were isolated from surgical tissues. The mRNA expressions of ␣-SMA, collagen types I and III, and Nox4 were determined by reverse transcription-polymerase chain reaction, and the expression of ␣-SMA protein was determined by immunocytochemical staining. The amount of total collagen production was analyzed by SirCol collagen dye-binding assay. ROS activity was measured by nitroblue tetrazolium reduction assay, and visualized by fluorescent microscopy. RESULTS: In TGF␤1-induced NPDFs, EM and RXM significantly inhibited expressions of ␣-SMA and collagen type I and III mRNA and reduced ␣-SMA and collagen protein levels at concentrations of 5 g/ml and 10 g/ml. EM and RXM also inhibited TGF␤1-induced ROS production and Nox4 mRNA expression at the same concentrations. CONCLUSION: These results speculate that EM and RXM may play an important role in inhibiting the development of nasal polyps through their anti-oxidant effect.
Effect of Steroid Treatments on Apoptosis Level of Polyp
Atila Gungor, MD (presenter); Burak Kapucu, MD; Engin Cekin, MD; Hakan Cincik, MD OBJECTIVE: In this study, apoptosis rates in the polyp tissue induced by the different ways of the glucocorticoid treatments were compared with each other and control group. METHOD: This study was performed on 48 patients with nasal polyposis in the Otorhinolaryngology Clinic of GATA Haydarpasa Training Hospital in years 2008 -2009. Patients were randomly assigned into four groups and each group included 12 patients. Group A was treated with oral metilprednisolone 1 mg/kg/day and the dose tapered gradually. In group B, 0.3 ml triamcinolone acetonid (40 mg/ml) was injected into polyp tissue bilaterally. Group C was treated topicaly with 55 g triamcinolone acetonid two times daily for 1 month. Group D (the control group) was given no medication. Samples were collected endoscopically in clinic during examination or in operation room during surgery. Apoptotic index of the polyp tissue in each group was determined by terminal deoxynucleotidyl transferase mediated dUTP Nick End Labelling (TUNEL) method. RESULTS: A statistically significant difference was found between apopitotoc indexes of all steroid medicated groups and control group (pD-Aϭ0.0001; pD-Bϭ 0.003; pD-Cϭ 0.026). We also determined statistically significant difference between apopitotic index of group A and group C (pA-Cϭ 0.012). There was no statistically significant difference between apopitotic indexes of group B and group A and group C (pA-Bϭ 0.11; pB-Cϭ 0.75). CONCLUSION: These findings indicate that oral, topical and intrapolyp injection forms of glucocorticoids induce apoptosis in nasal polyp tissue when compared with the control group. We also found a statistically significant difference on induction of apoptosis between oral with spray forms of glucocorticoids in treatment.
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